Bayer Advances 225Ac-PSMA-Trillium to Next Phase Following Promising Phase I Data in mCRPC

225Ac-PSMA-Trillium (BAY 3563254) is an investigational targeted alpha therapy (TAT) being developed for patients with advanced metastatic castration...

March 02, 2026 | Monday | News
SteinCares and Shilpa Biologicals Forge Strategic Biosimilar Partnership to Expand Access Across Latin America

New partnership combines Shilpa Biologicals' development and manufacturing capabilities with SteinCares' regional commercialization...

February 27, 2026 | Friday | News
Mahzi Doses First Patient in Phase 1/2 Trial of MZ-1866, the First Investigational Gene Therapy for Pitt Hopkins Syndrome

First Investigational Gene Therapy for Pitt Hopkins Syndrome Intended to Address Underlying Disease Biology -- Mahzi Therapeutics Inc., a clinical...

February 27, 2026 | Friday | News
Bayer Sues Johnson & Johnson And Janssen Biotech Over Allegedly Misleading Prostate Cancer Drug Data

Bayer files false advertising suit against J&J and Janssen Biotech Lawsuit seeks preliminary and permanent injunctions in addition to damages. ...

February 25, 2026 | Wednesday | News
ImmunityBio Expands Global Footprint with ANKTIVA Commercialization Partnership in Middle East

Biopharma & Cigalah are two of the largest pharmaceutical commercial distributors in the Middle East and North Africa (MENA) ImmunityBio establi...

February 24, 2026 | Tuesday | News
Stellaromics Launches Pyxa™, the First Commercial Platform for Multiplexed 3D Spatial Transcriptomics in Intact Tissue

Stellaromics launched Pyxa™, the first commercially available platform to deliver multiplexed 3D spatial transcriptomics in intact tissue up to 100...

February 23, 2026 | Monday | News
Bio Usawa and Nanoly Bioscience Partner to Revolutionize Biologic and Vaccine Distribution with DynaShield™

Bio Usawa, a leader in expanding global access to biopharmaceuticals, and Nanoly Bioscience, a pioneer in chemical stabilization,  announced a defin...

February 19, 2026 | Thursday | News
QuidelOrtho Strengthens Global Immunoassay Portfolio Through Strategic Agreement With Lifotronic Technology

QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd. (Lifotronic Technology Co., Ltd., stock code: 68838...

February 17, 2026 | Tuesday | News
Agilent PD L1 IHC 22C3 PharmDx Secures FDA Approval To Guide KEYTRUDA In Ovarian Cancer

Approval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. announced ...

February 13, 2026 | Friday | News
Eccogene Reports Positive Phase 1b Results for Oral GLP-1 Candidate Elecoglipron in China

Elecoglipron demonstrated a favorable safety and tolerability profile in Chinese adults living with obesity/overweight with or without type 2 diabete...

February 12, 2026 | Thursday | News
Waters Expands into Global Diagnostics and Biosciences Powerhouse with BD Transaction Close

  Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors Forms a global life sciences and diagnostics leader focused on high-...

February 11, 2026 | Wednesday | News
Azenta Partners with Frontier Space to Advance Life Sciences Research in Microgravity

Azenta, Inc.  announced a strategic partnership with Frontier Space, a pioneer in commercial space-based research systems, to conduct cutting-edge s...

February 11, 2026 | Wednesday | News
Novartis Expands US Innovation Footprint with USD 23 Billion R&D Push, Including New San Diego Research Hub

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including C...

February 09, 2026 | Monday | News
From Symptoms to Systems: The Rise of Multiomics in Disease Research

  In this BioPharma Boardroom interview, Jason Causon, Senior Technical Product Manager for Accurate Mass Platforms at SCIEX, explores how multiomi...

February 04, 2026 | Wednesday | Interaction

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close